arsenic trioxide has been researched along with Diabetes Mellitus, Type 2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kalo, MB; Rezaei, M | 1 |
| Hai, X; Hostetter, TH; Lu, S; Pang, C; Wu, M | 1 |
| Bradley, TP; Budman, DR; Kritharis, A | 1 |
1 review(s) available for arsenic trioxide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The evolving use of arsenic in pharmacotherapy of malignant disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Biotransformation; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Gastrointestinal Diseases; Gene Expression Regulation; Heart Diseases; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Metabolic Networks and Pathways; Methyltransferases; Neoplasms; Oxides; Reactive Oxygen Species; Signal Transduction; Treatment Outcome | 2013 |
2 other study(ies) available for arsenic trioxide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
In vitro toxic interaction of arsenic and hyperglycemia in mitochondria: an important implication of increased vulnerability in pre-diabetics.
Topics: Animals; Apoptosis; Arsenic; Arsenic Trioxide; Arsenicals; Diabetes Mellitus, Type 2; Glucose; Glutathione; Hyperglycemia; Mitochondria; Oxides; Prediabetic State; Rats; Reactive Oxygen Species | 2022 |
Type 2 diabetes affects arsenic metabolism via transporters in arsenic trioxide treated acute promyelocytic leukemia patients.
Topics: Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Diabetes Mellitus, Type 2; Glucose; HEK293 Cells; Humans; Leukemia, Promyelocytic, Acute; Oxides | 2023 |